Healthcare Stocks Breakout and Biotech Stocks Rally Off the Bottom…Update-3 ALNY AMRN
Update-3 10/20...China Phase 1 deal stalled -curbs strong momentum in biopharma. Amarin (AMRN) getting beat up by an Oppenheimer skeptic who thinks Vascepa growth will be tepid. Despite tape slowing many stocks saw huge gains: ASND NKTR SRPT etc. Per comment on 10/18 RNAi area heating up on...
Nice Gains for Biotech Today Big and Small…Update-2
Update-2...One of the best days of the year for us; I will summarize later. Only laggard sector was speculative microcaps. Some of our best gains among healthcare/life science stocks: ABBV AMRN CRSP GILD ILMN TDOC UNH VCYT XBI ======= Update-1... Biotech gains Curbed by macro--global turmoil...
Biotech and Healthcare Stocks Notch-Up with Bullish Tape Action
Biotech and Healthcare Stocks Notch -Up with Bullish Tape Action Since we called the early October reversal for healthcare and biotech stocks we have seen great gains of 5-7% with more gains ahead assuming good clinical news and M&A. Friday we saw a good tape with a 2.54% gain in the XBI...
Biotech Action Today is Muddled
Biotech Action Today is Muddled-Midday Selloff presumably on "Recycling" of China Trade Chatter Uncertainty Remains on Trade War and Tariffs Little rally in gene therapy stocks; 1% + Winners include QURE RGNX SRPT; XBI up only 0.26% as rally faded. Mixed tape in mid-caps: Notable winners MRNA...
Biotech had a Great October Boosted by Large Cap Biopharma Leader…Update-1 AMRN, REGN
Update-1 11/5 2p EST IBB flat, NAZ up 0.185, earnings from AMRN and REGN. Amarin down 3.5% to $16.83 on earnings but bulls are waiting for label expansion. Q3 Revenues are $112.4 M up 103%, increased prescriptions for Vascepa with a 12/28/19 PADUFA date. Regeneron (REGN) up 8.25% to $336.60 on...